Norges Bank purchased a new stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 8,505,446 shares of the medical research company’s stock, valued at approximately $648,540,000. Norges Bank owned approximately 1.40% […]
PNC Financial Services Group Inc. trimmed its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 6.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 677,251 shares of the medical research company’s stock after selling […]
Robeco Institutional Asset Management B.V. lessened its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 44.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 309,870 shares of the medical research company’s stock after selling 244,472 […]
First National Advisers LLC increased its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 39.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,185 shares of the medical research company’s stock after purchasing an […]
First National Advisers LLC boosted its stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 39.7% in the fourth quarter, HoldingsChannel reports. The firm owned 29,185 shares of the medical research company’s stock after acquiring an additional 8,296 shares during the period. First National Advisers LLC’s holdings in Edwards Lifesciences were worth $2,225,000 at […]